Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • ASCI Milestone Awards
    • Video Abstracts
    • Conversations with Giants in Medicine
  • Reviews
    • View all reviews ...
    • The cGAS-STING pathway: DNA sensing in health and disease (Jun 2026)
    • Neurodegeneration (Mar 2026)
    • Clinical innovation and scientific progress in GLP-1 medicine (Nov 2025)
    • Pancreatic Cancer (Jul 2025)
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • ASCI Milestone Awards
  • Video Abstracts
  • Conversations with Giants in Medicine
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Journal stats
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
The interaction of Synapsin 2a and Synaptogyrin-3 regulates fear extinction in mice
Xi-Ya Shen, Juan Zhang, He-Zhou Huang, Shao-Dan Li, Ling Zhou, Shi-Ping Wu, Cheng Tang, Xian Huang, Zhi-Qiang Liu, Zi-Yuan Guo, Xiang Li, Heng-Ye Man, You-Ming Lu, Ling-Qiang Zhu, Dan Liu
Xi-Ya Shen, Juan Zhang, He-Zhou Huang, Shao-Dan Li, Ling Zhou, Shi-Ping Wu, Cheng Tang, Xian Huang, Zhi-Qiang Liu, Zi-Yuan Guo, Xiang Li, Heng-Ye Man, You-Ming Lu, Ling-Qiang Zhu, Dan Liu
View: Text | PDF
Research Article Neuroscience

The interaction of Synapsin 2a and Synaptogyrin-3 regulates fear extinction in mice

  • Text
  • PDF
Abstract

The mechanisms behind a lack of efficient fear extinction in some individuals are unclear. Here, by employing a principal components analysis–based approach, we differentiated the mice into extinction-resistant and susceptible groups. We determined that elevated synapsin 2a (Syn2a) in the infralimbic cortex (IL) to basolateral amygdala (BLA) circuit disrupted presynaptic orchestration, leading to an excitatory/inhibitory imbalance in the BLA region and causing extinction resistance. Overexpression or silencing of Syn2a levels in IL neurons replicated or alleviated behavioral, electrophysiological, and biochemical phenotypes in resistant mice. We further identified that the proline-rich domain H in the C-terminus of Syn2a was indispensable for the interaction with synaptogyrin-3 (Syngr3) and demonstrated that disrupting this interaction restored extinction impairments. Molecular docking revealed that ritonavir, an FDA-approved HIV drug, could disrupt Syn2a-Syngr3 binding and rescue fear extinction behavior in Syn2a-elevated mice. In summary, the aberrant elevation of Syn2a expression and its interaction with Syngr3 at the presynaptic site were crucial in fear extinction resistance, suggesting a potential therapeutic avenue for related disorders.

Authors

Xi-Ya Shen, Juan Zhang, He-Zhou Huang, Shao-Dan Li, Ling Zhou, Shi-Ping Wu, Cheng Tang, Xian Huang, Zhi-Qiang Liu, Zi-Yuan Guo, Xiang Li, Heng-Ye Man, You-Ming Lu, Ling-Qiang Zhu, Dan Liu

×

Figure 7

Blocking the Syn2a/Syngr3 interaction by P-2A preserves presynaptic function and promotes fear extinction.

Options: View larger image (or click on image) Download as PowerPoint
Blocking the Syn2a/Syngr3 interaction by P-2A preserves presynaptic func...
(A) A diagram illustrates that P-2A disrupts the binding of Syn2a with Syngr3 in the presynapse. (B) The H293T cells were transfected with EGFP-Syn2a and HA-Syngr3 plasmids. After 24 hours, cells were treated with P-2A for 12 hours. Cell lysates were then collected for Co-IP assay. (C) WT mice were intraperitoneally injected with P-2A or S-2A. mPFC homogenates were collected and immunoprecipitated (IP) by using the anti-Syn2a. Representative immunoblots (upper) and quantification (lower) (n = 5 per group). (D) Representative Western blots (upper) and quantification (lower) of the protein levels of Syn2a and Syn2b in P-2A and S-2A treated mice (n = 3 replicates). (E) The mPFC lysates were precipitated with rabbit VAMP2 antibody, and probed with anti-Syntaxin and anti-SNAP25. (F) Quantitative analysis of Co-IP (n = 5–6 per group). (G) Representative traces (left) and quantification (right) of sEPSCs from BLA interneurons in P-2A or S-2A treated WT or Syn2a-E mice (n = 10 neurons from 3 mice per group). (H) Average freezing response for all trials during fear acquisition, extinction retrieval, and extinction of WT + S-2A, WT + P-2A, Syn2a-E + S-2A, and Syn2a-E + P-2A groups in mice (n = 5–8 per group). (I and J) Freezing response during the extinction training sessions (I) and testing sessions (J) of WT + S-2A, WT + P-2A, Syn2a-E + S-2A, and Syn2a-E + P-2A groups in mice (n = 5–8 per group). Statistical analyses among multiple groups were conducted using 1-way (F and G) or 2-way (H) ANOVA followed by Bonferroni post hoc tests, whereas an unpaired 2-tailed t test was conducted for comparing 2 groups (C, D, I, and J). *P< 0.05, **P < 0.01, ***P < 0.001. Values are presented as mean ± SEM.

Copyright © 2026 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts